PDF(Pubmed)
Abstract：
UNASSIGNED: Intraabdominal and retroperitoneal leiomyosarcomas are rare cancers, which cause significant morbidity and mortality. Symptoms, treatment and follow up differs from other cancers, and proper diagnosis and treatment of intraabdominal and retroperitoneal leiomyosarcomas is of utmost importance. We performed a systematic review to collect and summarize available evidence for diagnosis and treatment for these tumours.
UNASSIGNED: We performed a systematic literature search of Pubmed from the earliest entry possible, until January 2021. Our search phrase was (((((colon) OR (rectum)) OR (intestine)) OR (abdomen)) OR (retroperitoneum)) AND (leiomyosarcoma). All hits were evaluated by two of the authors.
UNASSIGNED: Our predefined search identified 1983 hits, we selected 218 hits and retrieved full-text copies of these. 144 studies were included in the review.
UNASSIGNED: This review summarizes the current knowledge and evidence on non-uterine abdominal and retroperitoneal leiomyosarcomas. The review has revealed a lack of high-quality evidence, and randomized clinical trials. There is a great need for more substantial and high-quality research in the area of leiomyosarcomas of the abdomen and retroperitoneum.
UNASSIGNED: PROSPERO, identifier, CRD42023480527.
UNASSIGNED: We performed a systematic literature search of Pubmed from the earliest entry possible, until January 2021. Our search phrase was (((((colon) OR (rectum)) OR (intestine)) OR (abdomen)) OR (retroperitoneum)) AND (leiomyosarcoma). All hits were evaluated by two of the authors.
UNASSIGNED: Our predefined search identified 1983 hits, we selected 218 hits and retrieved full-text copies of these. 144 studies were included in the review.
UNASSIGNED: This review summarizes the current knowledge and evidence on non-uterine abdominal and retroperitoneal leiomyosarcomas. The review has revealed a lack of high-quality evidence, and randomized clinical trials. There is a great need for more substantial and high-quality research in the area of leiomyosarcomas of the abdomen and retroperitoneum.
UNASSIGNED: PROSPERO, identifier, CRD42023480527.
摘要：
■腹内和腹膜后平滑肌肉瘤是罕见的癌症，导致显著的发病率和死亡率。症状,治疗和随访不同于其他癌症，腹内和腹膜后平滑肌肉瘤的正确诊断和治疗至关重要。我们进行了系统评价，以收集和总结这些肿瘤的诊断和治疗的可用证据。
■我们从最早的条目开始对Pubmed进行了系统的文献检索，直到2021年1月。我们的搜索短语是（（（（结肠）或（直肠））或（肠））或（腹部）或（腹膜后））和（平滑肌肉瘤）。所有点击由两位作者评估。
■我们预定义的搜索确定了1983次命中，我们选择了218次点击，并检索了这些点击的全文副本。144项研究纳入审查。
■这篇综述总结了关于非子宫腹部和腹膜后平滑肌肉瘤的现有知识和证据。审查显示缺乏高质量的证据,和随机临床试验。在腹部和腹膜后平滑肌肉瘤领域非常需要更多实质性和高质量的研究。
■PROSPERO，标识符,CRD42023480527。
■我们从最早的条目开始对Pubmed进行了系统的文献检索，直到2021年1月。我们的搜索短语是（（（（结肠）或（直肠））或（肠））或（腹部）或（腹膜后））和（平滑肌肉瘤）。所有点击由两位作者评估。
■我们预定义的搜索确定了1983次命中，我们选择了218次点击，并检索了这些点击的全文副本。144项研究纳入审查。
■这篇综述总结了关于非子宫腹部和腹膜后平滑肌肉瘤的现有知识和证据。审查显示缺乏高质量的证据,和随机临床试验。在腹部和腹膜后平滑肌肉瘤领域非常需要更多实质性和高质量的研究。
■PROSPERO，标识符,CRD42023480527。
